The Senate Health, Education, Labor, and Pensions Committee held a confirmation hearing on July 15, 2026, for two key nominees within the Centers for Disease Control and Prevention (CDC). Dr. Erica Schwartz, nominated by President Donald Trump in April 2026, appeared before the committee to be considered for CDC director. She was joined by Sean Kaufman, nominated as assistant secretary for preparedness and response.
Part 1: Immediate Action & Core Facts
The hearing comes amid significant instability at the CDC, including leadership turnover, a shooting incident, and public skepticism about the agency's effectiveness. Schwartz, a former deputy surgeon general and retired U.S. Coast Guard officer, is Trump's third pick for the role after previous nominees faced challenges. If confirmed, she would replace Dr. Jay Bhattacharya, who has served as acting director since February 2026.
Part 2: Deeper Dive & Context
Background on the Nominees
Schwartz earned her medical degree from Brown University and served in the U.S. Navy until 2005. She later worked in the U.S. Public Health Service Commissioned Corps and as the Coast Guard Chief Medical Officer. Her nomination has been praised by some health officials, including Dr. Richard Besser, former acting CDC director under President Obama, who noted her extensive public health experience.
Challenges at the CDC
The agency has faced multiple crises, including an Ebola outbreak in central Africa and a surge in parasitic diarrhea cases across several U.S. states. A White House official reportedly described the search for a new director as prioritizing stability, stating, "We just need someone who’s not crazy." Schwartz’s selection contrasts with earlier contenders, some of whom were criticized for vaccine skepticism.
Political and Public Reactions
Schwartz’s nomination has drawn mixed reactions. While some Capitol Hill figures have expressed support, others have questioned the administration’s handling of the CDC’s leadership. The agency has struggled with morale issues and public trust, compounded by rapid leadership changes and high-profile incidents.
Long-Term Implications
The confirmation process will determine whether Schwartz can restore stability to the CDC amid ongoing public health challenges. Her background in vaccination programs and crisis response may position her to address current and future outbreaks effectively.